Aquabounty Technologies Inc
Aquabounty Technologies Inc is a biotechnology company focused on developing and commercializing aquaculture products.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Aquabounty Technologies' stock with a target price of $2, indicating growth potential.
Financial Health
Aquabounty Technologies is generating modest revenue and cash flow, but financial performance is limited.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AQB
Blue-Carbon & Ocean Health
Dive into a carefully selected group of stocks that are leading the blue economy revolution. These companies were hand-selected by our expert analysts for their innovative approaches to ocean sustainability, from advanced aquaculture to ecosystem restoration and marine technology.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth Efficiency Case
AquAdvantage salmon aims to reach market size faster, which could lower unit costs if scaled; however, commercial adoption and economics remain uncertain.
Sustainable Aquaculture
Genetic improvements may support more efficient farming and reduced resource use, though consumer acceptance and regulation could limit market access.
Regulatory Watch
Past regulatory milestones matter for sales and exports; any future approvals or restrictions will materially affect prospects, and the small market cap adds risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
